Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 1545-5009, Iss. 11, 2015-11 ,pp. : 2050-2051

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 270-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rapid and sensitive allele-specific (AS)-RT-PCR assay for detection of T315I mutation in chronic myeloid leukemia patients treated with tyrosine-kinase inhibitors

By Manrique Arechavaleta Gonzalo   Scholl Vanesa   Pérez Verónica   Bittencourt Roberta   Moellmann Arthur   Hassan Rocio   Seuánez Héctor   Dobbin Jane   Martinez Lem   Renault Ilana   Uriarte Rosario  

Clinical and Experimental Medicine, Vol. 11, Iss. 1, 2011-03 ,pp. : 55-59

Springer Publishing Company

Access to resources Recommend Favorite

Ph‐negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph‐positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1070-1071

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dasatinib in the Treatment of Chronic Myeloid Leukemia

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 1, 2011-01 ,pp. : 99-105

Bentham Science Publishers

Access to resources Recommend Favorite